Uni-Bio Science Group Limited
UNBSF
$0.0036
$0.00360.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 19.60% | 19.37% | 9.78% | 9.71% | -3.97% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.60% | 19.37% | 9.78% | 9.71% | -3.97% |
| Cost of Revenue | 20.37% | 20.14% | -15.53% | -15.58% | -24.83% |
| Gross Profit | 19.43% | 19.21% | 16.28% | 16.21% | 1.99% |
| SG&A Expenses | 24.21% | 23.98% | -5.74% | -5.79% | -7.33% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 54.13% | 54.20% | 55.45% | 55.46% | -998.24% |
| Total Operating Expenses | 26.72% | 26.48% | -1.82% | -1.88% | -8.09% |
| Operating Income | -18.40% | -18.55% | 64.32% | 64.22% | 26.24% |
| Income Before Tax | -39.31% | -39.42% | 65.32% | 65.22% | 16.22% |
| Income Tax Expenses | 313.35% | 312.61% | 4.48% | 4.40% | -75.01% |
| Earnings from Continuing Operations | -50.85% | -50.94% | 71.49% | 71.38% | 31.98% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -50.85% | -50.94% | 71.49% | 71.38% | 31.98% |
| EBIT | -18.40% | -18.55% | 64.32% | 64.22% | 26.24% |
| EBITDA | -21.09% | -21.24% | 63.73% | 63.63% | 37.75% |
| EPS Basic | -33.33% | -33.33% | 75.00% | 75.00% | 50.00% |
| Normalized Basic EPS | -50.00% | -50.00% | 66.67% | 66.67% | 0.00% |
| EPS Diluted | -33.33% | -33.33% | 75.00% | 75.00% | 50.00% |
| Normalized Diluted EPS | -50.00% | -50.00% | 66.67% | 66.67% | 0.00% |
| Average Basic Shares Outstanding | -3.90% | -3.90% | -3.16% | -3.16% | 0.13% |
| Average Diluted Shares Outstanding | -3.90% | -3.90% | -3.16% | -3.16% | 0.13% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |